Costs and barriers of cancer screening after positive genetic testing: Are actionable mutations becoming unactionable? Editorial

  

Authors:	Kahn, R. M.; Gordhandas, S.; Aviki, E.; Long Roche, K.
Title:	Costs and barriers of cancer screening after positive genetic testing: Are actionable mutations becoming unactionable?
Keywords:	genetics; mutation; note; neoplasm; neoplasms; cancer susceptibility; cancer prevention; genetic variability; cancer screening; practice guideline; risk assessment; health care quality; health care cost; medicaid; medicare; insurance; health care personnel; high risk population; risk reduction; awareness; genetic screening; early detection of cancer; cost benefit analysis; health care access; genetic testing; preventive health service; high throughput sequencing; social media; humans; human; early cancer diagnosis
Journal Title:	Journal of the National Comprehensive Cancer Network
Volume:	20
Issue:	6
ISSN:	1540-1405
Publisher:	Harborside Press
Date Published:	2022-06-01
Start Page:	616
End Page:	617
Language:	English
DOI:	10.6004/jnccn.2022.7013
PUBMED:	35714670
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132455396&doi=10.6004%2fjnccn.2022.7013&partnerID=40&md5=d4c1ae3e669070bc5fbda8ad91cf66a3
Notes:	Note -- Export Date: 1 August 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/196254